Dynamics of intercellular communication during melanoma development

Molecular Medicine Today

Volumn 6, Issue 4, 2000, Pages 163-169

  Li, Gang ^a   Herlyn, Meenhard ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CELL ADHESION MOLECULE; GAP JUNCTION PROTEIN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; NERVE CELL ADHESION MOLECULE; RECEPTOR PROTEIN; UVOMORULIN; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; APOPTOSIS; CARCINOGENESIS; CELL ADHESION; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CHICK EMBRYO; HUMAN; MALIGNANT TRANSFORMATION; MELANOMA; MELANOSOME; NONHUMAN; PROTEIN EXPRESSION; REVIEW;

ANIMALS; CADHERINS; CELL ADHESION MOLECULES; CELL COMMUNICATION; GAP JUNCTIONS; HUMANS; MELANOMA; SKIN NEOPLASMS;

ANIMALIA;

EID: 0034176775     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(00)01692-0     Document Type: Review

References (51)

1. Rigel D.S.et al. Lifetime risk for development of skin cancer in the U.S. population: current estimate is now 1 in 5. J. Am. Acad. Dermatol. 35:1996;1012-1013.
2. Parker S.L.et al. Cancer statistics. Cancer Clin. 47:1997;5-27.
3. Meier F.et al. Molecular events in melanoma development and progression. Front. Biosci. 3:1998;D1005-D1010.
4. Tucker M.A.et al. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. J. Am. Med. Assoc. 277:1997;1439-1444.
5. Rhodes A.R. Neoplasms: Benign neoplasia, hyperplasias, and dysplasias of melanocytes. Fitzpatrick T.B.et al. Dermatology in General Medicine. 1993;996-1077 McGraw-Hill.
6. Valyi-Nagy I.T.et al. Undifferentiated keratinocytes control growth, morphology, and antigen expression of normal melanocytes through cell-cell contact. Lab. Invest. 69:1993;152-159.
7. Shih I.M.et al. Regulation of Mel-CAM/MUC18 expression on melanocytic cells of different stages of tumor progression by normal keratinocytes. Am. J. Pathol. 145:1994;837-845.
8. Herlyn M., Shih I-M. Interactions of melanocytes and melanoma cells with the micro-environment. Pigment Cell Res. 7:1994;81-88.
9. Scott G.A., Haake A.R. Keratinocytes regulate melanocytes number in human fetal and neonatal skin equivalents. J. Invest. Dermatol. 97:1991;776-781.
10. Xie S.et al. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res. 57:1997;2295-2303.
11. Kageshita T.et al. Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma. Cancer Res. 53:1993;4927-4932.
12. Martin-Padura I.et al. Heterogeneity in human melanoma cell adhesion to cytokine activated endothelial cells correlates with VLA-4 expression. Cancer Res. 51:1991;2239-2241.
13. Nesbit M., Herlyn M. Adhesion receptors in human melanoma progression. Invasion Metastasis. 14:1995;131-146.
14. Vleminckx K., Kemler R. Cadherins and tissue formation: integrating adhesion and signaling. BioEssays. 21:1999;211-220.
15. Guilford P. E-cadherin downregulation in cancer: fuel on the fire? Mol. Med. Today. 5:1999;172-177.
16. Christofori G., Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem. Sci. 24:1999;73-76.
17. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am. J. Pathol. 153:1998;333-339.
18. Tang A.et al. E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. J. Cell Sci. 107:1994;983-992.
19. Hsu M.Y.et al. Shifts in cadherin profiles between human normal melanocytes and melanomas. J. Invest. Dermatol. Symp. Proc. 1:1996;188-194.
20. Danen E.H.et al. E-cadherin expression in human melanoma. Cancer Res. 6:1996;127-131.
21. Meier F.et al. Human melanoma progression in skin reconstructs: Biological significance of bFGF. Am. J. Pathol. 156:2000;193-200.
22. Hsu M-Y.et al. E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am. J. Pathol. 2000;. (in press).
23. Frenzel E.M., Johnson R.G. Gap junction formation between cultured embryonic lens cells is inhibited by antibody to N-cadherin. Dev. Biol. 179:1996;1-16.
24. Sanders D.S.et al. Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours. Mol. Pathol. 52:1999;151-157.
25. Murphy M.et al. Neural stem cells. J. Invest. Dermatol. Symp. Proc. 2:1997;8-13.
26. Nishimura E.K.et al. Microenvironmentally accordant expression of cadherins associated with melanocyte migration and differentiation. Pigment Cell Res. Suppl. 7:1999;62.
27. Furukawa F.et al. Roles of E- and P-cadherin in the human skin. Microsc. Res. Tech. 38:1997;343-352.
28. Tran N.L.et al. N-cadherin expression in human prostate carcinoma cell lines - an epithelial-mesenchymal transformation mediating adhesion with stromal cells. Am. J. Pathol. 155:1999;787-798.
29. Husmark J.et al. N-cadherin-mediated adhesion and aberrant catenin expression in anaplastic thyroid-carcinoma cell lines. Int. J. Cancer. 83:1999;692-699.
30. Kawamura-Kodama K.et al. N-cadherin expressed on malignant T cell lymphoma cells is functional, and promotes heterotypic adhesion between the lymphoma cells and mesenchymal cells expressing N-cadherin. J. Invest. Dermatol. 112:1999;62-66.
31. Knudsen, K.A. et al. (1998) A role for cadherin in cellular signaling and differentiation. J. Cell. Biochem. 30-31, 168-176.
32. Islam S.et al. Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblast phenotype with disrupted cell-cell adhesion. J. Cell Biol. 135:1996;1643-1654.
33. Nieman M.T.et al. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J. Cell Biol. 147:1999;631-643.
34. DeLuca S.M.et al. Hepatocyte growth factor/scatter factor promotes a switch from E- to N-cadherin in chick embryo epiblast cells. Exp. Cell Res. 251:1999;3-15.
35. Otsuka T.et al. c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype. Cancer Res. 58:1998;5157-5167.
36. Voura E.B.et al. Cell-cell interactions during transendothelial migration of tumor cells. Microsc. Res. Tech. 43:1998;265-275.
37. Hazan R.B.et al. N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes. Commun. 4:1997;399-411.
38. Williams E.J.et al. Activation of the FGF receptor underlies neurite outgrowth stimulated by L1, N-CAM, and N-cadherin. Neuron. 13:1994;583-594.
39. Doherty P., Walsh F.S. Signal transduction events underlying neurite outgrowth stimulated by cell adhesion molecules. Curr. Opin. Neurobiol. 4:1994;49-55.
40. Yamasaki H.et al. Role of connexin (gap junction) genes in cell growth control and carcinogenesis. C. R. Acad. Sci. Ser. III. 322:1999;151-159.
41. Mehta P.P.et al. Growth inhibition of transformed cells correlates with their junctional communication with normal cells. Cell. 44:1986;187-196.
42. Esinduy C.et al. In vitro growth inhibition of neoplastically transformed cells by non-transformed cells: requirement for gap junctional intercellular communication. Carcinogenesis. 16:1995;915-921.
43. Goldberg G.S.et al. Selective transfer of endogeneous metabolites through gap junctions composed of different connexins. Nat. Cell Biol. 1:1999;457-459.
44. Trosko J.E., Ruch R.J. Cell-cell communication in carcinogenesis. Front. Biosci. 3:1999;208-236.
45. Xie H.et al. A mitosis-specific phosphorylation of the gap junction protein connexin43 in human vascular cells: biochemical characterization and localization. J. Cell Biol. 137:1997;203-210.
46. Zhu D.et al. Transfection of C6 glioma cells with connexin 43 cDNA: analysis of expression, intercellular coupling, and cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 88:1991;1883-1887.
47. Yamasaki H.et al. Genetic and epigenetic changes of intercellular communication genes during multistage carcinogenesis. Cancer Detect. Prev. 23:1999;273-279.
48. Saez J.C.et al. Regulation of gap junctions by protein phosphorylation. Braz. J. Med. Biol. Res. 31:1998;593-600.
49. Zhang W.et al. Direct gap junction communication between malignant glioma cells and astrocytes. Cancer Res. 59:1999;1994-2003.
50. Lecanda F.et al. Gap junctional communication modulates gene expression in osteoblastic cells. Mol. Biol. Cell. 9:1998;2249-2258.
51. Fukata M.et al. Cell adhesion and Rho small GTPases. J. Cell Sci. 112:1999;4491-4500.